Nachrichten zur Illumina Inc. Aktie

Illumina delivers first NovaSeq X Plus sequencer to the Broad Institute

New data on NovaSeq X Plus and workflow insights on Illumina Complete Long Reads unveiled at AGBT HOLLYWOOD, Fla., Feb.…

Illumina (ILMN) Q4 Earnings Miss Estimates, Gross Margin Down

Delays in recruitment for some large research projects in the Americas and Europe, the impact of COVID disruptions in China…

Illumina in EU hearing to fight order to divest GRAIL

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Illumina fights EU order to divest Grail

...By Foo Yun Chee BRUSSELS, Feb 8 (Reuters) - U.S. life science company......…

Illumina (ILMN) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

While the top- and bottom-line numbers for Illumina (ILMN) give a sense of how the business performed in the quarter…

Illumina swings to net loss in 2022; fourth quarter revenue drops 10%

Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…

Illumina (ILMN) Misses Q4 Earnings Estimates

Illumina (ILMN) delivered earnings and revenue surprises of -26.32% and 1.54%, respectively, for the quarter ended December 2022. Do the…

Illumina Inc. Q4 Earnings Summary

SAN DIEGO (dpa-AFX) - Below are the earnings highlights for Illumina Inc. (ILMN):Earnings: -$140 million in Q4 vs. $112 million…

Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2022

Revenue of $1.08 billion for Q4 2022, down 10% from Q4 2021, and down 7% on a constant currency basis…

Illumina Non-GAAP EPS of $0.14 misses by $0.05, revenue of $1.08B beats by $10M

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Illumina Attracts Challengers for DNA Sequencing Ahead of Earnings

Illumina competitors are out in force this week at the sequencing industry's annual gathering. The company reports fourth-quarter and year…

Form 8-K ILLUMINA, INC. For: Feb 01

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Illumina: How Organizations Around the World Are Closing the Cancer Care Gap

NORTHAMPTON, MA / ACCESSWIRE / February 3, 2023 / IlluminaOriginally published on Illumina News CenterAccording to the World Health Organization,…

Guardant Health Says Illumina Has No Basis For Challenging Ownership Of Its Patents

SAN DIEGO (dpa-AFX) - Guardant Health Inc. (GH) said it continues to believe that Illumina has no basis for challenging…

Form 8-K ILLUMINA, INC. For: Jan 31

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Illumina Named to Bloomberg Gender Equality Index for Fifth Consecutive Year

NORTHAMPTON, MA / ACCESSWIRE / February 1, 2023 / Illumina has been included in the 2023 Bloomberg Gender-Equality Index for…

Illumina Confirms Joydeep Goswami As New CFO

SAN DIEGO (dpa-AFX) - Illumina, Inc. (ILMN), a DNA sequencing and array-based technologies firm, announced Wednesday that Joydeep Goswami has…

Joydeep Goswami is the new finance chief of Illumina

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Illumina Appoints Joydeep Goswami Chief Financial Officer

SAN DIEGO, Feb. 1, 2023 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies,…

Illumina: Video: UK Festival of Genomics & Biodata Inspires and Connects Genomics Leaders

NORTHAMPTON, MA / ACCESSWIRE / January 31, 2023 / IlluminaOriginally published on Illumina News CenterThe Festival of Genomics & Biodata…

Illumina downgraded to hold at Argus on poor near-term outlook

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Illumina: Kursziel reduziert

Vancouver (www.aktiencheck.de) - Rating-Update: Kyle Mikson, Analyst von Canaccord Genuity, bewertet die Aktie des Sequenzierungsspezialisten Illumina Inc. (ISIN: US4523271090, WKN:…

Illumina CEO on Earnings Outlook, Buying Grail

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Illumina facing huge fine from EU over closing GRAIL deal without antitrust approval

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Exclusive-Illumina to face EU fine of 10% of turnover over Grail deal -sources

...By Foo Yun Chee BRUSSELS (Reuters) - U.S. life sciences company......…

Insiderhandel: SVP, Chief Commercial Officer verkauft Aktien von Illumina im Wert von 102.290$

Tousi, Susan H. - Vorstand - Tag der Transaktion: 2023-01-06...…

Illumina to Announce Fourth Quarter and Full Year 2022 Financial Results on Tuesday, February 7, 2023

SAN DIEGO, Jan. 10, 2023 /PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN) announced today that it will issue results for the fourth…

Why Illumina Has Grown Cautious and What It Means for the Stock

The gene-sequencing company grew sensationally during the pandemic, but sales moderated in the second half of 2022. Now it expects…

UPDATE 1-Illumina challenges EU order to keep Grail separate

... (Reuters) - U.S. life sciences company Illumina on Tuesday challenged......…

Illumina challenges EU order to keep Grail separate

...By Foo Yun Chee BRUSSELS (Reuters) - U.S. life sciences company......…

Illumina Plunges 16% on Weaker-Than-Expected 2023 Profit Outlook

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Illumina, Amgen to genome sequence 35K DNA samples

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Illumina and Nashville Biosciences Announce Sequencing Agreement with Amgen

Whole-genome sequencing of 35,000 de-identified, diverse genomic DNA samples will begin this month SAN DIEGO, Jan. 9, 2023 /PRNewswire/ --…

Illumina: Coverage-Aufnahme

Toronto (www.aktiencheck.de) - Rating-Update: Sung Ji Nam, Analyst der Scotiabank, nimmt die Coverage der Aktie von Illumina Inc. (ISIN: US4523271090,…

Form 8-K ILLUMINA, INC. For: Jan 04

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Are Options Traders Betting on a Big Move in Illumina (ILMN) Stock?

Investors need to pay close attention to Illumina (ILMN) stock based on the movements in the options market lately....…

Illumina To Webcast Upcoming Investor Conference

SAN DIEGO, Dec. 19, 2022 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at…

Cancer researchers question antitrust arguments against Illumina-Grail deal

...By Deena Beasley and Julie Steenhuysen LOS ANGELES/CHICAGO (Reuters... competing test developers need to thrive. But Reuters interviews......…

FOCUS-Cancer researchers question antitrust arguments against Illumina-Grail deal

... (Reuters) - U.S. and European antitrust enforcers want to unwind gene... the technology competing test developers need to thrive. But Reuters interviews......…

Illumina-Aktie: Besteht noch Hoffnung für Anleger?

Die Illumina-Aktie (WKN: 927079) hat seit Mitte 2021 eine schlechte Performance abgeliefert. Sie hat sich gegenüber dem damaligen Kurs mehr…

Is Illumina Cheap or Expensive?

It depends on which numbers you focus on....…

Illumina Ranks Among Top Scores on Dow Jones Sustainability Index and CDP

As of December 9, 2022 Illumina awarded highest score from S&P Dow Jones Indices in Life Sciences Tools & Services…

Illumina defends $7.1 billion Grail buy to fend off antitrust regulators

...By Diane Bartz WASHINGTON (Reuters) - U.S. life sciences company......…

Illumina defends $7.1 bln Grail buy to fend off antitrust regulators

...By Diane Bartz WASHINGTON, Dec 13 (Reuters) - U.S. life sciences......…

Insights on the NGS Kits Global Market to 2032 - Featuring Agilent Technologies, BGI, Hologic, Illumina, New England Biolabs and Takara Bio Among Others

DUBLIN, Dec. 13, 2022 /PRNewswire/ -- The "NGS Kits Market - A Global and Regional Analysis: Focus on Workflow, Sequencing…

Illumina: Downgrade

New York (www.aktiencheck.de) - Rating-Update: Patrick Donnelly, Analyst der Citigroup, stuft die Aktie von Illumina Inc. (ISIN: US4523271090, WKN: 927079, Ticker-Symbol…

Insiderhandel: SVP, Chief Commercial Officer verkauft Aktien von Illumina im Wert von 106.315$

Tousi, Susan H. - Vorstand - Tag der Transaktion: 2022-12-06...…

EU charge sheet tells Illumina to swiftly unwind Grail deal

...By Foo Yun Chee BRUSSELS (Reuters) -EU antitrust regulators on Monday......…

UPDATE 1-EU charge sheet tells Illumina to swiftly unwind Grail deal

... (Reuters) - EU antitrust regulators on Monday proposed measures for U.S......…

EU Tells Illumina How to Unwind Deal to Buy Cancer-Test Developer Grail

The European Commission said Illumina will have to restore Grails independence and return it to the same level that existed…